EichorEICHOR
Study identifier: NCT07660692 Synced from ClinicalTrials.gov · August 03, 2026
● Completed

Guishen Yijing Formula for Diminished Ovarian Reserve: A Real-World Retrospective Study

Condition: Diminished Ovarian Reserve (DOR)  ·  Sponsor: Shi Yun

PhaseN/A
Planned participants126
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the real-world effectiveness of Guishen Yijing Formula in women with diminished ovarian reserve (DOR). The main question it aims to answer is: Does Guishen Yijing Formula improve ovarian reserve function in women with DOR after 3 months of treatment? Medical records of participants who received Guishen Yijing Formula as part of their routine clinical care for DOR will be reviewed. Changes in anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), and symptom scores before and after treatment will be analyzed.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Dongzhimen Hospital, Beijing University of Chinese MedicineBeijing, China

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →